Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 85 M89 M100 M96 M111 M 396 M Research & development 8 M9 M10 M10 M9 M 38 M Operating income 494 M521 M542 M489 M753 M 2.31 B Non-Operating Income, Total -9 M-14 M-10 M-7 M-2 M -33 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -9 M-14 M-10 M-8 M-2 M -34 M Unusual income/expense 0001 M— — Pretax income 446 M469 M495 M430 M708 M 2.1 B Equity in earnings ————— — Taxes 102 M62 M110 M58 M128 M 358 M Non-controlling/minority interest ————— — After tax other income/expense -3 M1 M-1 M-5 M-3 M -8 M Net income before discontinued operations 344 M407 M385 M372 M580 M 1.74 B Discontinued operations ————— — Net income 344 M407 M385 M372 M580 M 1.74 B Dilution adjustment 00000 0 Preferred dividends 1 M01 M00 1 M Diluted net income available to common stockholders 343 M407 M384 M372 M580 M 1.74 B Basic earnings per share (Basic EPS) 0.851.010.960.911.45 4.33 Diluted earnings per share (Diluted EPS) 0.8410.950.921.44 4.31 Average basic shares outstanding 405 M404 M403 M404 M401 M — Diluted shares outstanding 407 M406 M405 M406 M403 M — EBITDA 555 M594 M728 M741 M734 M 2.8 B EBIT 494 M525 M656 M668 M660 M 2.51 B Cost of revenue 1.29 B1.36 B1.36 B1.41 B1.46 B 5.6 B Other cost of goods sold 1.29 B1.36 B1.36 B1.41 B1.46 B 5.6 B Depreciation & amortization (cash flow) 69 M69 M72 M73 M74 M 288 M